Follow us:

News & events

  • Home
  • News & informations

Ypso-Facto invests 1.4M€ in the development of a collaborative software suite for process design and evaluation

The company has received 800k€ from European Regional Development Fund (ERDF) to support the development of Ypso-Proxima®

  • by Ypso-Facto
  • January 14, 2021
Nancy, France, January 14th, 2021 - Ypso-Facto, a company specialized in the development and optimization of processes for the Life Sciences Industries invests 1.4M€, including € 800,000 from the European Regional Development Fund (ERDF), to support the development of its software suite Ypso-Proxima®...

Read more

NEW ARTICLE - Comparison of mAb single-use DSP processes by Sanofi using Ypso-Proxima

EASY: a disruptive mAb purification process to reduce cost of goods

  • by Ypso-Facto
  • January 08, 2021
This article [1] illustrates how Ypso-Proxima allows a rational comparison between two biopharmaceutical DSP processes. The innovative EASY mAb purification process developed by Sanofi is matched against the standard proteinA-based DSP counterpart. Relying on Proxima's process evaluation, the...

Read more

UP-COMING WEBINAR - Manufacturing in the industry 4.0 era: how to balance innovation with performance while not being disrupted

10th March, with C. Varsakelis (Janssen), Mark Demesmaeker (Sartorius) and RM Nicoud (Ypso-Facto)

  • by Ypso-Facto
  • January 07, 2021
FREE webinar! Save your seat now by registering online, here .

Read more

Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
© Ypso-Facto 2014 - Powered by Ealys | Legal Information